Characteristics and recognition of early infections in patients treated with commercial anti‐CD19 CAR‐T cells-Reference-Cited by-同舟云学术

Characteristics and recognition of early infections in patients treated with commercial anti‐CD19 CAR‐T cells

Published:2021-10-13 Issue:1 Volume:108 Page:52-60
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Beyar‐Katz Ofrat¹²,Kikozashvili Nino¹²,Bar On Yael¹²,Amit Odelia¹²,Perry Chava²³,Avivi Irit²³,Gold Ronit¹,Herishanu Yair²³^ORCID,Benyamini Noam²³,Duek Adrian⁴,Ben‐Ami Ronen²⁵,Shasha David²⁵,Ram Ron¹²

Affiliation:

1. BMT UnitTel Aviv Sourasky Medical Center Tel Aviv Israel

2. Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

3. Department of Hematology Tel Aviv Sourasky Medical Center Tel Aviv Israel

4. Hematology InstituteUniversity Hospital Assuta Ashdod Ashdod Israel

5. Infectious Diseases Unit Tel Aviv Sourasky Medical Center Tel Aviv Israel

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13712

Reference16 articles.

1. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

2. Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

3. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

4. Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma

5. Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic toxicity of CAR-T therapy and potential monitoring indicators for toxicity prevention;Frontiers in Immunology;2024-08-26

2. Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipients;Blood;2024-08-01

3. Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapy;Blood Advances;2024-07-12

4. Cytomegalovirus colitis presenting with lower gastrointestinal bleeding following chimeric antigen receptor‐T cell therapy;Journal of Cellular and Molecular Medicine;2024-07

5. Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape;Viruses;2024-03-24